Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma

Myriam Weyl Ben Arush, Ido Solt, Abraham Lightman, Shai Linn, Avraham Kuten

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to investigate the impact of therapy on long- term gonadal function of young people cured of childhood lymphomas and to assess whether a prepubertal state during the treatment protects the gonads from chemotherapy and/or radiotherapy late effects. Clinical evaluation, semen analysis, and endocrine status were studied in 20 survivors of childhood lymphomas. Five patients received Inverted Y radiotherapy, 2320 cGy (1550-4000); all 20 received chemotherapy as follows: MOPP/ABVD protocol, 9 patients; COMP protocol, 5 patients; MOPP protocol, 3 patients; other protocols, 3 patients. Semen analysis results were as follows: normal values, 4/20 patients; oligospermia, 8/20 patients; azoospermia, 8/20 patients; FSH above normal level, 10/20 patients; 4/5 who received Inverted Y irradiation were azoospermic and 1 was severely oligospermic. Treatment damage to the testis involves tubular germinal elements. Radiotherapy and chemotherapy combinations that included nitrogen mustard or cyclophosphamide were associated with high rates of oligospermia and azoospermia. MOPP/ABVD combination did not have a significant better outcome of sperm counts compared to MOPP alone. Age at chemotherapy did not correlate with the sperm count; hence a prepubertal state did not protect the gonad from the late effects of treatment.

Original languageEnglish
Pages (from-to)239-245
Number of pages7
JournalPediatric Hematology and Oncology
Volume17
Issue number3
DOIs
StatePublished - 2000
Externally publishedYes

Keywords

  • Cancer late effects
  • Fertility
  • Hodgkin
  • Lymphoma
  • Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this